Target intelligence / Profile preview

GREM1 antisense RNA 1 (GREM1-AS1)

Target
GREM1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

GREM1 antisense RNA 1 (GREM1-AS1) is a long non-coding RNA gene transcribed as an antisense strand relative to the GREM1 (Gremlin 1) gene locus[4]. As an antisense lncRNA, GREM1-AS1 is part of a class of RNAs that typically regulate gene expression by mechanisms such as transcriptional interference, chromatin remodeling, or modulating RNA processing[3][5]. While antisense RNAs are known to impact gene regulation both in cis and trans, detailed functional insights specific to GREM1-AS1 are currently lacking in authoritative databases and literature. There is no evidence that GREM1-AS1 is a therapeutic target or that it interacts with approved drugs, nor are there established clinical biomarkers or safety concerns associated with its modulation. GREM1-AS1 is a valid antisense lncRNA with limited characterization. It is not a conventional therapeutic target (such as a receptor or enzyme), and little is known about its precise biological or disease roles. No drugs, biomarkers, or safety concerns are associated with this RNA to date[4][5][3].

Other names
GREM1 Antisense RNA 1GREM1-AS1
02

Mechanism of action

Not applicable; no validated drugs or antisense oligonucleotides are documented to modulate GREM1-AS1 specifically.

03

Biological functions

Regulation of gene expression (likely in cis)Possible involvement in chromatin remodeling or transcriptional interferenceOther functions remain unclear and are under investigation.
04

Disease associations

Not definitively established; lncRNAs including antisense RNAs have been implicated in cancer and neurological disease in general, but specific disease roles for GREM1-AS1 are not clearly documented in authoritative sources.

Beyond the preview

Go deeper on GREM1 antisense RNA 1 (GREM1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GREM1 antisense RNA 1 (GREM1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call